FDA Internet Oversight “Ripe For Comment” In Free Speech Analysis – Lawyer
This article was originally published in The Rose Sheet
Executive Summary
FDA's regulation of claims made over the Internet is one aspect of policymaking that remains "ripe for comment" as the agency seeks public feedback on its regulatory decisions in light of recent First Amendment case law, Morgan Lewis partner Sandra Dennis opined
You may also be interested in...
FDA Commercial Speech Regs Constitutionality Debate Opened By Agency
FDA invites public comments on the constitutionality of its approach to regulating advertising and marketing practices for cosmetics, drugs and other products in a notice appearing in the May 16 Federal Register
Sunscreen, OTC Labeling Reg First Amendment Intrusions Cited By CTFA
FDA's sunscreen and OTC labeling final regs will have difficulty passing constitutional muster in light of a recent court decision requiring agency-drafted disclaimers for a folic acid health claim, the Cosmetic, Toiletry and Fragrance Association maintains.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program